Phase II trial of gefitinib plus pemetrexed after relapse using first-line gefitinib in patients with non-small cell lung cancer harboring EGFR gene mutations

Lung Cancer ◽

10.1016/j.lungcan.2018.07.031 ◽

2018 ◽

Vol 124 ◽

pp. 65-70 ◽

Cited By ~ 5

Author(s):

Ken Uchibori ◽

Miyako Satouchi ◽

Naoko Sueoka-Aragane ◽

Yoshiko Urata ◽

Akemi Sato ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Gene Mutations ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Egfr Gene

Download Full-text

Randomized, Multi-center Phase II Trial of Docetaxel Plus Cisplatin Versus Etoposide Plus Cisplatin as the First-line Therapy for Patients with Advanced Non-Small Cell Lung Cancer

Cancer Research and Treatment ◽

10.4143/crt.2005.37.6.332 ◽

2005 ◽

Vol 37 (6) ◽

pp. 332

Author(s):

Nam-Su Lee ◽

Hee-Sook Park ◽

Jong-Ho Won ◽

Dae-Sik Hong ◽

Su-Taek Uh ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Line Therapy

Download Full-text

Phase-II trial of taxotere (TXT) and Navelbine (N) as first-line therapy in patients (PTS) with advanced non-small cell lung cancer (ANSCLC)

Lung Cancer ◽

10.1016/s0169-5002(99)90743-2 ◽

1999 ◽

Vol 25 ◽

pp. S19-S20

Author(s):

M. O'Rourke ◽

D. Garfield ◽

P. Ellis

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Line Therapy

Download Full-text

Phase II Trial of Irinotecan plus Cisplatin Combination as First Line Therapy for Patients with Small cell Lung Cancer

Tuberculosis and Respiratory Diseases ◽

10.4046/trd.2006.60.1.57 ◽

2006 ◽

Vol 60 (1) ◽

pp. 57 ◽

Cited By ~ 1

Author(s):

Hye Cheol Jeong ◽

Sang Yeub Lee ◽

Jung Ha Kim ◽

Eun Sil Ha ◽

Jin Yong Jung ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Line Therapy

Download Full-text

Randomised Phase II Trial of Oral Vinorelbine (N) and Cisplatin (P) or Pemetrexed and C (PC) in First Line Advanced Non Squamous (NSCC) Non Small Cell Lung Cancer (NSCLC) Patients (PTS). Navotrial01: Final Results

Annals of Oncology ◽

10.1016/s0923-7534(20)33841-2 ◽

2012 ◽

Vol 23 ◽

pp. ix409

Author(s):

E.H. Tan ◽

L. Havel ◽

M.J. Krzakowski ◽

J. Kollmeier ◽

R. Gervais ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Oral Vinorelbine ◽

Nsclc Patients

Download Full-text

Phase II trial of a 2-h infusion of gemcitabine plus carboplatin as first-line chemotherapy for advanced non-small-cell lung cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-006-0237-2 ◽

2006 ◽

Vol 59 (1) ◽

pp. 1-7 ◽

Cited By ~ 10

Author(s):

N. Xu ◽

P. Shen ◽

X. C. Zhang ◽

L. F. Yu ◽

H. Y. Bao ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Line Chemotherapy

Download Full-text

Phase II trial of satraplatin (S) and paclitaxel (P) in first-line advanced non-small cell lung cancer (NSCLC) treatment: Final results

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.19023 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 19023-19023 ◽

Cited By ~ 1

Author(s):

D. S. Thompson ◽

D. R. Spigel ◽

J. D. Hainsworth ◽

S. F. Jones ◽

H. A. Burris ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

First Line

Download Full-text

P-457 Docetaxel/gemcitabine vs. cisplatin/gemcitabine followed bydocetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): Results of a randomised phase II trial

Lung Cancer ◽

10.1016/s0169-5002(05)80950-x ◽

2005 ◽

Vol 49 ◽

pp. S236-S237

Author(s):

D. Binder ◽

H. Schweisfurth ◽

C. Grah ◽

C. Schäper ◽

B. Temmesfeld-Wollbrück ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text

Phase II trial of weekly docetaxel and carboplatin as first line chemotherapy in advanced or metastatic non small cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7330 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7330-7330 ◽

Cited By ~ 1

Author(s):

G. Y. Chahine ◽

F. L. Nasr ◽

J. G. Kattan ◽

F. S. Farhat ◽

M.-E. El Seoudi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Weekly Docetaxel ◽

Line Chemotherapy

Download Full-text

Phase II trial of the multi-targeted antifolate LY231514 (MTA) as first-line therapy for patients with advanced non-small cell lung cancer (NSCLC)

European Journal of Cancer ◽

10.1016/s0959-8049(97)85830-3 ◽

1997 ◽

Vol 33 ◽

pp. S231 ◽

Cited By ~ 4

Author(s):

J. Rusthoven ◽

E. Eisenhauer ◽

C. Butts ◽

R. Gregg ◽

J. Dancey ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Line Therapy

Download Full-text

Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Bevacizumab in First-line Patients with Advanced Nonsquamous Non-small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3181c0a2f4 ◽

2009 ◽

Vol 4 (12) ◽

pp. 1537-1543 ◽

Cited By ~ 37

Author(s):

Craig Reynolds ◽

David Barrera ◽

Robert Jotte ◽

Alexander I. Spira ◽

Charles Weissman ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

First Line

Download Full-text